Psychedelic Assisted Therapy With DMT

To assess the therapeutic potential of DMT, Small Pharma is leading the world’s first DMT clinical trial for depression, in collaboration with Imperial College London.

Join Michelle Baker-Jones and Dr Graham Campbell (Lead Therapist and Study Psychiatrist for the Phase I/IIa trials) for this exclusive event, as they give a brief overview of this early trial and provide us with insight into the trial setting, the participants and their approach to psychedelic therapy with DMT. They will also share details of the participant journey through the trial and the broad nature of their experiences.